Winnow Wealth’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9
Closed -$3.16K 261
2025
Q4
$3.16K Buy
9
+7
+350% +$2.37K ﹤0.01% 328
2025
Q3
$648 Buy
+2
New +$622 ﹤0.01% 453
2025
Q2
Sell
-8
Closed -$3.19K 331
2025
Q1
$3.19K Buy
8
+3
+60% +$1.2K ﹤0.01% 270
2024
Q4
$1.81K Buy
+5
New +$2.09K ﹤0.01% 280

Other funds holding ELV

Winnow Wealth's ELV Position: Q1 2026 in Review

Winnow Wealth sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 9 shares — an estimated $3.16K sold.

Winnow Wealth first reported a position in ELV in Q4 2024 and held it in 4 quarters. The position peaked at $3.19K in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Winnow Wealth reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Winnow Wealth sold 9 Elevance Health shares in Q1 2026, an estimated $3.16K.
  • Winnow Wealth first reported a position in Elevance Health in Q4 2024 and held it in 4 quarters.
  • Winnow Wealth's Elevance Health position peaked at $3.19K in Q1 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Winnow Wealth's 13F filing for Q1 2026, filed 19 May 2026.